You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Suppliers and packagers for ADVIL PM


✉ Email this page to a colleague

« Back to Dashboard


ADVIL PM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393 NDA Haleon US Holdings LLC 0573-0148-06 1 BOTTLE in 1 CARTON (0573-0148-06) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE 2025-01-15
Haleon Us Holdings ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393 NDA Haleon US Holdings LLC 0573-0148-07 1 BOTTLE in 1 CARTON (0573-0148-07) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE 2025-01-15
Haleon Us Holdings ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393 NDA Haleon US Holdings LLC 0573-0167-25 1 BOTTLE in 1 CARTON (0573-0167-25) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE 2005-12-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: ADVIL PM

Last updated: July 31, 2025

Introduction

Advil PM, a prominent over-the-counter (OTC) medication combining ibuprofen and diphenhydramine, is widely used for pain relief and sleep aid. Its global distribution demands a robust supply chain composed of manufacturing entities, raw material vendors, and distribution channels. This article offers a detailed examination of the primary suppliers involved in the production of Advil PM, highlighting their roles, market positioning, and the implications for stakeholders across the pharmaceutical supply ecosystem.

Manufacturers of Advil PM

The primary manufacturer of Advil PM is Johnson & Johnson, operating through its consumer health division, Johnson & Johnson Consumer Inc. The company formulates, manufactures, and markets the drug, ensuring it adheres to strict regulatory standards. Johnson & Johnson’s extensive manufacturing capabilities enable consistent product quality and supply stability.

In addition to Johnson & Johnson, several third-party contract manufacturing organizations (CMOs) assist in producing the active pharmaceutical ingredients (APIs) and finished formulations. These CMOs often supply bulk API and handle downstream processing, encapsulation, packaging, and distribution. Notable CMOs serving the OTC segment include:

  • Catalent Pharma Solutions: Specializes in formulation development and manufacturing, including OTC products and APIs.
  • Recipharm: Provides development and manufacturing services for solid oral dosage forms.
  • Althea Technologies: Known for manufacturing APIs and finished dosage forms tailored to OTC products.

Raw Material Suppliers: Active Pharmaceutical Ingredients

Ibuprofen (API)

Ibuprofen is the primary API in Advil PM, sourced from a limited number of specialized chemical suppliers. Major providers include:

  • BASF: A leading supplier of pharmaceutical-grade APIs, including ibuprofen, with a global manufacturing footprint.
  • Mitsubishi Chemical: Supplies high-quality ibuprofen raw material used in multiple OTC and prescription products.
  • TAKASAGO: A Japanese producer offering pharmaceutical-grade ibuprofen with rigorous quality standards.

Doxylamine/Pyridoxine (if present in specific formulations)

While standard Advil PM contains diphenhydramine, formulations with pyridoxine or additional ingredients leverage suppliers such as:

  • Serum Institute of India: Provides various active ingredients for OTC medications.
  • Sun Pharmaceutical Industries: Supplies APIs, including antihistamines, for OTC formulations worldwide.

Excipients and Packaging Materials

Beyond APIs, the formulation includes excipients — fillers, stabilizers, and coloring agents — sourced from a variety of chemical suppliers:

  • Ashland Global Holdings
  • FMC Corporation
  • DuPont Nutrition & Health

Packaging components such as blister packs, bottles, caps, and labels are supplied by specialized packaging manufacturers like Berry Global and Amcor. These suppliers ensure compliance with pharmaceutical packaging regulations for safety and tamper evidence.

Distribution and Logistics

Once manufactured, Advil PM's distribution is managed through a network of wholesalers, pharmacies, and retail outlets. Major distributors include:

  • McKesson
  • AmerisourceBergen
  • Cardinal Health

These entities coordinate logistics to ensure product availability across regions.

Regulatory and Quality Standards

Suppliers of raw materials and intermediates must conform to Good Manufacturing Practices (GMP) guided by regulatory authorities such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national agencies. Johnson & Johnson sources from suppliers with proven compliance to mitigate risks related to contamination, quality lapses, and supply disruptions.

Supply Chain Challenges and Trends

The recent global supply chain disruptions, such as those caused by the COVID-19 pandemic, have spotlighted vulnerabilities within the OTC drug supply network. Dependence on a limited geographic base for APIs — notably regions like China and India — accentuates risks related to geopolitical considerations and manufacturing capacity constraints.

Emerging trends involve diversifying supplier bases, investing in regional manufacturing hubs, and leveraging technology for supply chain oversight. Johnson & Johnson has been active in these initiatives, aiming to secure the supply chain for Advil PM and similar OTC medications.

Implications for Stakeholders

Understanding suppliers' roles assists pharmaceutical companies, healthcare providers, and investors in assessing supply stability and risk management strategies. The concentrated API sourcing emphasizes the importance of diligent supplier qualification processes and contingency planning.

Conclusion

The supply chain for Advil PM encompasses a multifaceted network of manufacturers, raw material suppliers, excipient providers, packaging firms, and logistics companies. The dominant role of Johnson & Johnson underscores the importance of quality assurance and regulatory compliance throughout the process. Recognizing the geographic and operational dependencies within this chain is crucial for proactive risk mitigation and resilient supply planning.


Key Takeaways

  • Major manufacturer of Advil PM is Johnson & Johnson, with a global network of contract manufacturers and suppliers.
  • IBuprofen APIs are predominantly supplied by BASF, Mitsubishi Chemical, and TAKASAGO, with sourcing concentrated in certain regions.
  • Excipients and packaging are sourced from specialized chemical and packaging firms ensuring compliance with stringent pharmaceutical standards.
  • Supply chain risks from geopolitical and pandemic-related disruptions emphasize the need for diversification and regional manufacturing investments.
  • Stakeholders should prioritize supplier qualification, quality assurance, and contingency planning to safeguard product availability.

FAQs

Q1: Who are the primary suppliers of ibuprofen used in Advil PM?
BASF, Mitsubishi Chemical, and TAKASAGO are among the leading suppliers providing pharmaceutical-grade ibuprofen.

Q2: Does Johnson & Johnson manufacture all components of Advil PM?
While Johnson & Johnson formulates and markets Advil PM, it sources APIs, excipients, and packaging materials from specialized third-party manufacturers and suppliers.

Q3: How does global supply chain disruption affect Advil PM?
Disruptions in API manufacturing, especially in regions like China and India, can lead to shortages or increased costs, affecting product availability.

Q4: Are there alternative sources for Advil PM's ingredients?
Yes, manufacturing companies continually explore new suppliers and regional manufacturing options to diversify their supply base.

Q5: What measures are in place to ensure the quality of Advil PM supplies?
Suppliers must conform to GMP standards, and Johnson & Johnson conducts rigorous quality audits and supplier qualification processes to assure compliance.


Sources

[1] Johnson & Johnson Official Website. ("Johnson & Johnson Consumer Inc.").
[2] BASF. ("Pharmaceutical Ingredients").
[3] Mitsubishi Chemical. ("API Manufacturing Capabilities").
[4] Takasago. ("Pharmaceutical-grade Active Ingredients").
[5] Industry Reports on OTC Pharmaceutical Supply Chains.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.